Search for: "Sanofi S A"
Results 1 - 20
of 924
Sort by Relevance
|
Sort by Date
9 May 2024, 10:55 am
Other pharmaceutical giants, including GSK, Sanofi, and Boehringer Ingelheim, also face numerous lawsuits related to Zantac. [read post]
26 Apr 2024, 12:41 pm
Sanofi, 598 U.S. 594 (2023) and was struck by the Supreme Court’s statement that its 19th Century decision of Wood v. [read post]
23 Apr 2024, 10:28 am
Sanofi. [read post]
14 Apr 2024, 9:05 pm
In Panuwat, the defendant was an employee of Medivation, Inc., a mid-cap oncology firm that was resisting one hostile bidder (Sanofi S.A.) and encouraging another firm (Pfizer) to outbid Sanofi. [read post]
7 Apr 2024, 9:59 pm
Sanofi Pasteur Inc. [read post]
28 Mar 2024, 8:07 pm
Sanofi Pasteur Inc. [read post]
12 Mar 2024, 9:13 pm
Sanofi Pasteur Inc., affirming the Patent Trial and Appeal Board's (PTAB) determination that all claims of U.S. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
6 Mar 2024, 10:15 am
Sanofi Pasteur Inc. affirming lower rulings by the Patent Trial and Appeal Board (PTAB) that invalidated Pfizer’s patent claims and denied motions to amend (MTA). [read post]
6 Mar 2024, 10:15 am
Sanofi Pasteur Inc. affirming lower rulings by the Patent Trial and Appeal Board (PTAB) that invalidated Pfizer’s patent claims and denied motions to amend (MTA). [read post]
5 Mar 2024, 10:55 am
All notices of correction are posted and maintained on HRSA’s ceiling price website. [read post]
5 Mar 2024, 10:23 am
Sanofi Opinion. [read post]
23 Jan 2024, 9:01 pm
Allianz Allianz Global’s $145 million payout benefits shareholders of collapsed mutual funds that Allianz managed. [read post]
21 Jan 2024, 9:01 pm
In Illumina/Grail, the Fifth Circuit reviewed the Commission’s reversal of the ALJ’s dismissal of the complaint. [read post]
18 Jan 2024, 5:14 pm
Sanofi et al. [read post]
